Sponsored Resources

Shortcomings of early 27-G vitrectomy systems drove the development of new technologies designed to match or surpass the performance of larger-gauge systems. The DORC TDC VELOCE represents the latest advancement - a next-generation high-speed cutter that reaches its full potential when combined with the DORC EVA NEXUS surgical system.

Discover how Dr. Smita Agarwal expanded her refractive portfolio with ZEISS SMILE pro for hyperopia, and why this flapless approach delivered excellent outcomes for her first hyperopic patient.

Discover in this case how Dr. Tanit Wongwibulsin digitized his cataract surgery, enhancing efficiency and ensuring precise data management. This transformation allowed him to save time per procedure, nearly doubling his surgical volume. Additionally, the adoption of the digital workflow led to a substantial increase in cases involving premium IOLs.

Surgical microscopes have undergone significant changes over the past decade, moving from conventional optics toward digital platforms that redefine the boundaries of surgical visualization. My own transition from the ARTEVO® 800 (Carl Zeiss Meditec AG, Jena, Germany) to the ARTEVO® 850 microscope has provided a firsthand perspective on how these advancements translate into real-world clinical benefit—particularly in the management of vitreoretinal surgery.

In this insightful analysis, Dr. Joong Hun Kim presents real-world clinical outcomes with bilateral implantation of ZEISS AT ELANA 841P. Dr. Kim recommends AT ELANA® 841P as an excellent option for patients undergoing cataract surgery as its fully trifocal optical design translates into a full range of vision. He also introduces the so-called ‘ELISA’ approach for patients requiring astigmatic correction in one eye only, combining AT ELANA 841P and ZEISS AT LISA tri toric 939MP. Early objective and subjective clinical data from this novel approach reveal promising visual outcomes and high patient satisfaction

Dr. Arnaldo Espaillat decided to undergo ZEISS PRESBYOND and shares how his own experience led him to expand his refractive portfolio with this corneal-based approach for patients without cataracts.

Advances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.